| Arcutis Presents ZORYVE® (roflumilast) Data and Real-World Topical Corticosteroid Research at EADV and Fall Clinical |
Globe Newswire |
10/09 |
08:00 |
| New Study Shows Cortical Disarray Measurement (CDM®) Can Reflect Microscopic Patterns of Pathology in Frontotemporal Dementia |
Globe Newswire |
10/09 |
08:00 |
| CENTEL Announces Masternode Participation Model and Blockchain Development Roadmap |
Globe Newswire |
10/09 |
08:00 |
| Quince Therapeutics Relaunches as IRulya Therapeutics with a Focus on the Clinical Development of LAM-001, Targeting a Key Pathway in Pulmonary Disease |
Globe Newswire |
10/09 |
08:00 |
| Profound Medical and Telix Pharmaceuticals Enter Co-Education Agreement to Advance PSMA-Informed Prostate Care |
Globe Newswire |
10/09 |
07:45 |
| INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that AEVEX Corp. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit Before October 20, 2026 Deadline – AVEX |
Globe Newswire |
10/09 |
07:45 |
| What is SGI: Centralized Super Intelligence Governance Platforms to Stop ‘Skynet Scare’ (Veterans First for America) |
Globe Newswire |
10/09 |
07:38 |
| Aura Announces Preliminary Record High Production in Q3 2026 and 9M 2026 Production Results |
Globe Newswire |
10/09 |
07:30 |
| Alterity Therapeutics to Present at the Canaccord Genuity Drug and Device Conference |
Globe Newswire |
10/09 |
07:05 |
| Sagimet To Present Positive Full 52-Week Results from License Partner Ascletis' Phase 3 Open-Label Extension Clinical Trial of Denifanstat in Acne and Mechanistic Data at the 2026 Fall Clinical Dermatology Conference |
Globe Newswire |
10/09 |
07:00 |
| Balchem Corporation Announces Quarterly Conference Call for Third Quarter 2026 Financial Results on October 23, 2026 |
Globe Newswire |
10/09 |
07:00 |
| Errington Metals Corp. Begins Trading on the OTCQX Best Market |
Globe Newswire |
10/09 |
07:00 |
| Stillwater Critical Minerals Corp. Begins Trading on OTCQX Best Market |
Globe Newswire |
10/09 |
07:00 |
| Wrap Appoints Veteran Law Enforcement Leader John “Chappy” Chapman as Vice President of Training and Missions |
Globe Newswire |
10/09 |
07:00 |
| Robbins Geller Rudman & Dowd LLP, Girard Sharp LLP, and The Hall Firm, Ltd. Attorneys File Securities Class Action Against Compass, Inc. (NYSE: COMP) |
Globe Newswire |
10/09 |
07:00 |
| Teva Announces U.S. Food and Drug Administration (FDA) Approval of WELTRUZA™ (Olanzapine) For Extended-Release Injectable Suspension, as the First and Only Once-Monthly Subcutaneous Injectable Olanzapine for Adults with Schizophrenia |
Globe Newswire |
10/09 |
07:00 |
| AI Crawlers Turned Away More Than Twice as Often, a Check to Run Before an AI Visibility Audit |
Globe Newswire |
10/09 |
07:00 |
| Overmatch Ventures announces first annual Austin Deep Tech 50 |
Globe Newswire |
10/09 |
07:00 |
| X4 Pharmaceuticals to Host Virtual Investor Day on Thursday, October 29, 2026, Featuring Key Opinion Leaders |
Globe Newswire |
10/09 |
07:00 |
| GOOG, GOOGL Securities Alert: Lose Money on Your Alphabet Investment? BFA Law Notifies Investors of the Filed Securities Class Action over AI Issues |
Globe Newswire |
10/09 |
06:33 |
| LINC Securities Alert: Lose Money on Your Lincoln Educational Investment? BFA Law Notifies Investors of the Filed Securities Class Action over Admissions Issues |
Globe Newswire |
10/09 |
06:33 |
| YSS Securities Alert: Lose Money on Your York Space Investment? BFA Law Notifies Investors of the Filed Securities Class Action over Satellite Software Issues |
Globe Newswire |
10/09 |
06:33 |
| BBNX Securities Alert: Lose Money on Your Beta Bionics Investment? BFA Law Notifies Investors of the Filed Securities Class Action over Medical Device Safety Issues |
Globe Newswire |
10/09 |
06:32 |
| Yacht Club de Monaco’s Tuiga wins at Saint-Tropez |
Globe Newswire |
10/09 |
06:27 |
| OMODA & JAECOO’s September NEV Sales Reach 53,957 Units, Up 184% Year-on-Year, as Key European Markets Accelerate |
Globe Newswire |
10/09 |
06:19 |
